Back


29/11/2017
OxThera Strengthens Patent Portfolio for treatment of Hyperoxaluria
OxThera AB announced today that it has recently been granted two new US patents, three new European patents and patents in Canada, China, Hong-Kong, India and Japan. OxThera now holds proprietary rights to pharmaceutical [...]




X

X